Cirugía Española 2023 Power 4
Cirugía Española 2023 Power 4
Cirugía Española 2023 Power 4
CIRUGÍA ESPAÑOLA
www.elsevier.es/cirugia
Original article
* Corresponding author.
E-mail address: ane.abadmotos@osakidetza.eus (A. Abad-Motos).
1
Current address: Hospital Universitario Donostia, Paseo Doctor Beguiristain s/n. 20014. Donostia-San Sebastián. Spain
http://dx.doi.org/10.1016/j.cireng.2023.04.011
2173-5077/# 2023 AEC. Published by Elsevier España, S.L.U. All rights reserved.
Please cite this article in press as: Ripollés-Melchor J, et al. Association between use of enhanced recovery after surgery protocols and
postoperative complications after gastric surgery for cancer (POWER 4): a nationwide, prospective multicentre study. Cir Esp. 2023. http://
dx.doi.org/10.1016/j.cireng.2023.04.011
CIRENG 2881 1–13
n
Department of Anaesthesia and Perioperative Medicine, Hospital de Sant Joan Despı́ Moisès Broggi, Spain
o
Department of Anaesthesia and Perioperative Medicine, Hospital Universitario de Alava, Vitoria, Spain
p
Department of Anesthesiology and Critical Care, Hospital Clı́nic, Institut D’investigació August Pi i Sunyer, Barcelona, Spain
q
Department of Anaesthesia and Perioperative Medicine, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain
r
Department of Anaesthesia and Perioperative Medicine, Hospital General Universitario Gregorio Marañón, Madrid, Spain
s
Department of Internal Medicine, Hospital Moisès Broggi, Consorci Sanitari Integral, Sant Joan Despı́, Spain
t
Department of Anaesthesia and Perioperative Medicine, Hospital General Universitari Castelló, Castellón de La Plana, Spain
u
Department of General Surgery, Hospital Galdakao-Usansolo, Spain
v
Department of General Surgery, Fundación Jiménez Dı́az University Hospital, Madrid, Spain
w
Banco de Sangre y Tejidos de Navarra, Pamplona, Spain
x
Department of Anaesthesia and Perioperative Medicine, Hospital Clı́nico de Valladolid, Spain
y
Department of Anaesthesia and Perioperative Medicine, Complexo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain
z
Department of General Surgery, Hospital General La Mancha Centro, Alcázar de San Juan, Spain
aa
Department of Anaesthesia and Perioperative Medicine, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain
ab
Department of General Surgery, Nuestra Señora de Candelaria Hospital Universitario, Spain
ac
Department of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
ad
Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA,
USA
ae
Department of Anaesthesia and Perioperative Medicine, Hospital Universitario Rı́o Hortega, Valladolid, Spain
af
Department of Anaesthesia and Perioperative Medicine, Juan Ramón Jiménez University Hospital, Huelva, Spain
ag
Department of Anaesthesia and Perioperative Medicine, Hospital Costa del Sol, Marbella, Spain
ah
Department of Anaesthesia and Perioperative Medicine, Complejo Hospitalario Universitario de Ourense, Ourense, Spain
ai
Department of Anaesthesia and Perioperative Medicine, Hospital Medina del Campo, Medina del Campo, Spain
aj
CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain
ak
Department of General Surgery, Lozano Blesa University Hospital, Universidad de Zaragoza, Zaragoza, Spain
ar ticle i n f o abstract
Article history: Introduction: The effectiveness of the Enhanced Recovery After Surgery (ERAS) protocols in
Received 27 December 2022 gastric cancer surgery remains controversial.
Accepted 21 February 2023 Methods: Multicentre prospective cohort study of adult patients undergoing surgery for
Available online xxx gastric cancer. Adherence with 22 individual components of ERAS pathways were assessed
in all patients, regardless of whether they were treated in a self-designed ERAS centre. Each
Keywords: centre had a three-month recruitment period between October 2019 and September 2020.
ERAS The primary outcome was moderate-to-severe postoperative complications within 30 days
gastric surgery after surgery. Secondary outcomes were overall postoperative complications, adherence to
postoperative complications the ERAS pathway, 30 day-mortality and hospital length of stay (LOS).
perioperative management Results: A total of 743 patients in 72 Spanish hospitals were included, 211 of them (28.4 %)
optimization from self-declared ERAS centres. A total of 245 patients (33 %) experienced postoperative
enhanced recovery complications, graded as moderate-to-severe complications in 172 patients (23.1 %). There
were no differences in the incidence of moderate-to-severe complications (22.3% vs. 23.5%;
OR, 0.92 (95% CI, 0.59 to 1.41); P = 0.068), or overall postoperative complications between the
self-declared ERAS and non-ERAS groups (33.6% vs. 32.7%; OR, 1.05 (95 % CI, 0.70 to 1.56);
P = 0.825). The overall rate of adherence to the ERAS pathway was 52% [IQR 45 to 60]. There
were no differences in postoperative outcomes between higher (Q1, > 60 %) and lower (Q4,
45 %) ERAS adherence quartiles.
Conclusions: Neither the partial application of perioperative ERAS measures nor treatment in
self-designated ERAS centres improved postoperative outcomes in patients undergoing
gastric surgery for cancer.
Trial Registration: ClinicalTrials.gov Identifier NCT03865810
# 2023 AEC. Published by Elsevier España, S.L.U. All rights reserved.
Please cite this article in press as: Ripollés-Melchor J, et al. Association between use of enhanced recovery after surgery protocols and
postoperative complications after gastric surgery for cancer (POWER 4): a nationwide, prospective multicentre study. Cir Esp. 2023. http://
dx.doi.org/10.1016/j.cireng.2023.04.011
CIRENG 2881 1–13
Methods
Introduction
Study design and participants
Gastric cancer is the fifth most frequent malignant tumour
worldwide, and accounts for 732,000 deaths per year, ranking The POWER 4study was a multicentre, prospective, three-
it as the fourth leading cause of cancer-related death.1 month cohort study. The study was approved by the Ethics
Gastrectomy for cancer is a technically challenging procedure, Committee of the Instituto Aragonés de Ciencias de la Salud,
with postoperative complications occurring in 20 to 46 % of Zaragoza, Spain (C.P.-C.I. PI19/106, March 27, 2019) and was
patients2,3 prospectively registered (NCT03865810). The study protocol
Enhanced Recovery After Surgery (ERAS) is a multidisci- was published,12 and approved by the ethics committees or
plinary perioperative approach that provides standardized institutional review boards of each centre. All patients signed
evidence-based recommendations for the care of patients a written informed consent before inclusion. This study
undergoing specific types of surgery.4 ERAS began in patients followed the STROBE reporting guideline for cohort studies,13
undergoing colorectal surgery,5 and resulted in a decrease in and the Reporting on ERAS Compliance, Outcomes, and
postoperative complications and length of hospital stay (LOS) Elements Research Checklist.14 The hospital and investigator
when adequate adherence to the protocols was achieved.6,7 involvement were provided through the Spanish Perioperative
The ERAS model is well established for colorectal surgery as Audit and Research Network (RedGERM). All Spanish centres
the optimal perioperative care. ERAS implementation in were invited to participate regardless of having or not an
gastric surgery8 has shown discrete decreases in LOS.9 established ERAS pathway.
Moreover, despite the clinical reported benefits of ERAS, its
implementation in clinical practice has been quite slow for a Procedures
variety of reasons, such as lack of convincing data, low level of
knowledge about ERAS, or expertise and institutional limita- All consecutive adult patients scheduled for elective gastric
tions,10,11 and lack of large studies assessing the association surgery for cancer were assessed for inclusion during a single
between ERAS adherence and postoperative outcomes. period of three months of recruitment at each participating
The aim of this study was to assess perioperative care in hospital between October 2019 and October 2020. Subtotal and
patients undergoing elective gastric surgery for cancer in total gastrectomies were included, both laparoscopic and
Spain, and to analyse the association between the individual open. Exclusion criteria were emergency surgery, endoscopic
ERAS elements and postoperative complications. procedures, non-oncological gastric surgery and patient
Please cite this article in press as: Ripollés-Melchor J, et al. Association between use of enhanced recovery after surgery protocols and
postoperative complications after gastric surgery for cancer (POWER 4): a nationwide, prospective multicentre study. Cir Esp. 2023. http://
dx.doi.org/10.1016/j.cireng.2023.04.011
CIRENG 2881 1–13
refusal. Each patient was followed up for 30 days after surgery. performed for each ERAS element. We then analysed the rate
Patient information was acquired from hospital and primary of moderate-to-severe complications for each ERAS element
care medical records. using Fisher’s exact test, and we performed a multivariate
Data was collected using the Castor EDC platform15 in a analysis to study the association between the rate of each of
case record form designed specifically for POWER 4. Centres the ERAS elements and the clinical and demographic
declared themselves as centres with or without an established variables. We also used the same model in a multilevel
multidisciplinary ERAS pathway for gastric surgery, regardless multivariable logistic regression model to explore indepen-
of the items that conformed the pathway and their current dent factors associated with moderate-to-severe postopera-
adherence. tive complications assessing the variability of each centre.
The definition of the individual ERAS components was In order to avoid errors in the multiple comparisons, the
based on the ERAS Society1 Guidelines for gastric surgery.8 respective q value was calculated for each P value in order to
For a simpler and more accurate data collection, some of the 25 maintain a false discovery rate of less than 5 %. Comparisons
items of these guidelines8 were grouped and POWER4 included in which the P value and q value were less than 0.05 were
22 elements of perioperative care12 (Table S1 supplementary considered statistically significant.
data).
Data included patient characteristics, surgical procedure,
surgical approach, duration of surgery, preoperative labora-
Results
tory results, ERAS elements, and 30-day outcomes (postope-
rative complications, LOS, readmission, reoperation, and 30- Participants
day mortality). Thirty-day postoperative complications were
predefined and graded as mild, moderate, or severe as A total of 743 patients from 72 centres were included in the
described by the European Perioperative Clinical Outcome analysis (Fig. 1), of which 211 (28.4%) were included in self-
definitions (EPCO)16 (Table S2, supplementary data). declared ERAS centres; 444 (60 %) were men, and median age
Data was censored at 30 days following surgery for patients was 70 years [IQR 61 to 77]. Other characteristics are shown in
who remained at the hospital. To ensure the validity of the Table 1. More patients in the ERAS group received preoperative
data, they were validated and audited by another site neoadjuvant therapy and were treated in a centre with a
investigator who was not involved in the initial data Patient Blood Management (PBM) program. Duration of
collection. Our aim was to recruit as many hospitals and surgery was longer in the ERAS group. (Table 1).
patients in Spain as possible.
Outcomes in self-declared ERAS vs. non-ERAS groups
Outcomes
A total of 172 patients (23.1%) suffered moderate-to-severe
The primary outcome measure was 30-day moderate-to- complications, and 245 patients (33 %) experienced overall
severe postoperative complications. Secondary outcomes postoperative complications. There were no differences in the
were occurrence of overall postoperative complications, incidence of moderate-to-severe complications (47 (22.3%) vs.
adherence to the ERAS pathway, 30 day-mortality and LOS.
Adherence to the ERAS pathway was defined as the
percentage of ERAS items that were applied to each patient
over the total number of interventions recommended by the
ERAS Society.
Statistical analysis
Please cite this article in press as: Ripollés-Melchor J, et al. Association between use of enhanced recovery after surgery protocols and
postoperative complications after gastric surgery for cancer (POWER 4): a nationwide, prospective multicentre study. Cir Esp. 2023. http://
dx.doi.org/10.1016/j.cireng.2023.04.011
CIRENG 2881 1–13
125 (23.5%); OR, 0.92 (95% CI, 0.59 to 1.41); P = 0.068) or overall most of the individual ERAS elements was higher in the self-
postoperative complications (71 (33.6%) vs. 174 (32.7%); OR, declared ERAS cohort. Table 2 shows the adherence for each of
1.05, 95 % CI, 0.70 to 1.56; P = 0.825) between the self-declared the individual ERAS elements.
ERAS and non-ERAS groups. Patients in the ERAS group had
less bloodstream infection compared to the non-ERAS group. Outcomes in higher versus lower ERAS adherence groups
There were no differences in the rest of the predefined
complications and there were no differences in readmissions, Adherence to the ERAS elements in the highest adherence
reoperations, mortality and LOS. (Fig. 2). quartile (Q1) was > 60 %, while in the lowest adherence
quartile (Q4) 45 %. There were no differences in the number
Adherence data of patients with moderate to severe complications, overall
complications, readmissions, mortality or LOS. Patients in the
The overall adherence rate to the ERAS individual items was Q1 had more anastomotic leak compared with those in the low
52% [IQR 45 to 60]. Adherence was significantly higher in self- adherence group (Q4). There were no other differences in any
declared ERAS centres compared to non-ERAS centres 60% of the predefined complications between the highest and
[IQR 52 to 70] vs. 50% [IQR 43 to 57] (P < 0.001). Adherence to lowest adherence groups (Fig. 3). Linear adherence adjustment
Please cite this article in press as: Ripollés-Melchor J, et al. Association between use of enhanced recovery after surgery protocols and
postoperative complications after gastric surgery for cancer (POWER 4): a nationwide, prospective multicentre study. Cir Esp. 2023. http://
dx.doi.org/10.1016/j.cireng.2023.04.011
CIRENG 2881 1–13
Fig. 2 – Title: Postoperative outcomes. Complications in all included patients and in patients who did or did not receive the
Enhanced Recovery After Surgery (ERAS) protocol.
Note. Data are expressed as number (%) or median (Q1-Q3).
Please cite this article in press as: Ripollés-Melchor J, et al. Association between use of enhanced recovery after surgery protocols and
postoperative complications after gastric surgery for cancer (POWER 4): a nationwide, prospective multicentre study. Cir Esp. 2023. http://
dx.doi.org/10.1016/j.cireng.2023.04.011
CIRENG 2881 1–13
Fig. 3 – Title: Postoperative outcomes and Enhanced Recovery After Surgery (ERAS) adherence.
Postoperative complications in all included patients depending on the quartile (Q) of adherence to the ERAS protocol.
Note. Data are expressed as number (%) or median (Q1-Q3).
also showed that additional adherence to the ERAS pathway in Individual ERAS elements and patients characteristics and
the Q1 did not improve any of the outcomes compared to Q4. LOS
Individual ERAS elements, patients characteristics and LOS was significantly lower in patients in whom nasogastric
moderate-to-severe postoperative complications tube was not used, and in those who received early feeding.
However, patients who underwent total gastrectomy and
Multivariable and multilevel analyses of individual ERAS those who received postoperative nutritional support had a
elements showed a statistically significant reduction of longer LOS. None of the other ERAS elements, neither being
moderate-to-severe complications in those patients in which treated at a self-declared ERAS centre, were associated with
early mobilization was achieved while patients not receiving shorter LOS (Table S4, supplementary data).
preoperative mechanical bowel preparation and postoperative
nutritional care had more moderate-severe postoperative
complications. No other associations were found for the other
Discussion
ERAS elements (Table S3, supplementary data.).
Patients who received neoadjuvant therapy had a lower The main finding of this study was that neither treatment at a
risk of moderate-severe postoperative complications. Frail self-declared ERAS centre nor high compliance (Q1) with ERAS
patients, patients with cirrhosis, patients undergoing total measures were associated with improved outcomes after
gastrectomy, and patients with a longer lasting surgery had a elective gastric cancer surgery.
higher risk of moderate-to-severe complications (Table S3, Given the success of ERAS in colorectal surgery, this
supplementary data). multimodal perioperative care approach has emerged as an
Please cite this article in press as: Ripollés-Melchor J, et al. Association between use of enhanced recovery after surgery protocols and
postoperative complications after gastric surgery for cancer (POWER 4): a nationwide, prospective multicentre study. Cir Esp. 2023. http://
dx.doi.org/10.1016/j.cireng.2023.04.011
CIRENG 2881 1–13
optimal perioperative strategy to improve clinical outcomes in patients with neoadjuvant therapy presented fewer complica-
gastric cancer surgery and in many other procedures. However, tions, but longer surgeries and total gastrectomy were associated
numerous controversies exist regarding the practice of ERAS in with more postoperative complications. On the other hand,
patients undergoing gastrectomy. A recent meta-analysis of although the partial application of ERAS did not lead to better
randomized controlled trials which assessed the role of ERAS in outcomes, it was not associated with more readmissions or more
radical gastrectomy showed that ERAS results in accelerated reoperations, so its practice seems safe, and efforts should be
convalescence, improved nutritional status, and improved undertaken to achieve greater adherence to the protocol, since it
quality of life for gastric cancer patients.17 Similarly to our is ultimately the standard of care in many cases.
findings, Blumenthaler et al did not find that the application of an Most of the studies on gastric surgery were performed in the
ERAS pathway in gastric surgery resulted in fewer postoperative Asian population, and this study is the largest study to date on
complications.18 It has been reported that the efficacy of gastric surgery in the ERAS setting in a Western population;
protocols that are incompletely or incipiently applied is markedly however, we must acknowledge some limitations of the study.
reduced.18,19 Although this has been mainly reported for First, in an optimally designed study, the groups would be blindly
colorectal surgery 6,20 it was also recently shown that greater assigned to ERAS or non-ERAS for the same period of time to
adherence to ERAS recommendations for gastric surgery resulted avoid allocation bias. However, we consider that a randomized
in improved postoperative outcomes.21 However, we did not find clinical trial comparing an ERAS protocol versus a clinical
that greater adherence to protocols was associated with better practice in which none of the ERAS elements were used would be
outcomes, although the adherence in our highest adherence unethical. On the other hand, information bias may be inherent
quartile was lower than previously reported as required to in the design of this study, and could have influenced an increase
improve postoperative outcomes6, so it is possible that our low in adherence to the ERAS elements, so that the actual ERAS
overall adherence in Spain was one of the determinants of the adherence could even be lower. The elements of ERAS
ineffectiveness of the ERAS protocol in this cohort. themselves are interrelated. For example, conservative intrao-
Early mobilization was the only ERAS element that was perative fluid administration is arguably more applicable in
associated with fewer moderate-severe complications. Several patients who did not receive preoperative bowel preparation,
studies have shown that the application of this part of the ERAS and administration of carbohydrate drinks mandates adequate
program can significantly accelerate the recovery of postope- adherence to preoperative fasting time. In addition, the use of
rative intestinal function22,23 and improve postoperative outco- some of the ERAS elements are related to the severity of the
mes.7,24,25 On the other hand, those who received postoperative patient, e.g., goal-directed fluid therapy, usually recommended
nutritional support had more postoperative complications and for the high-risk patient.33,34 We tried to avoid selection bias by
higher LOS probably due to a previous poorer nutritional status or including a majority of Spanish centres that were performing
the presence of postoperative complications.. The length of stay gastrectomy, regardless of whether they self-designated as ERAS
was also shorter in patients who did not have a nasogastric tube or not. The effect of these problems was partly offset by the large
and who received an early feeding. The number and relative sample size and the number of institutions reporting data, but
combination of ERAS elements implemented, and the relative we also have to recognize that gastrectomy is not as frequent a
importance of individual items, especially those considered as procedure as, for example, colorectal surgery, and many centres
"core elements’’ of ERAS is currently a debated topic.26,27 It is recruited a low number of patients.
accepted that early mobilization is a core element in most ERAS The application of ERAS protocols for gastric surgery in our
guidelines4, its fulfilment may be due to both a dedicated effort by cohort was very low. Neither partial compliance with ERAS
the postoperative multidisciplinary team and a sign of favourable protocols nor treatment with self-designated ERAS centres
clinical outcome,28 and conversely, the inability to mobilize early improved postoperative outcomes in patients undergoing
in the immediate postoperative period may be considered as a gastric surgery for cancer.
warning sign of poor clinical outcome.29 Early deviation of
postoperative ERAS elements appears to be the most significant
in terms of association with ERAS failure and delayed dis-
Funding
charge.29 Early restoration of the oral feeding promotes early
recovery of normal bowel function, so it seems logical that Support was only provided by institutional sources. The
patients who achieve early tolerance will have a shorter LOS,30 POWER 4 study was supported by the Spanish Perioperative
while those with impediments to achieving this, such as the Audit and Research Network (RedGERM) and the Grupo
presence of a nasogastric tube or the need for nutritional support, Español de Rehabilitación Multimodal (GERM).
will have a longer LOS. Once again, this postoperative element RedGERM conducted and designed the study; provided
could be considered as a success of the pathway, or as an early collection and management of the data; but had no role in the
warning sign in those cases in which compliance is not analysis and interpretation of the data; preparation, review, or
achieved.31 approval of the manuscript; and decision to submit the
A recent study provided unique insight into changes in manuscript for publication.
gastric cancer presentation, management and outcomes over a
30-year period and highlighted the importance of perioperative
chemotherapy in long-term survival, as well as the reduction in
COI/Disclosures
the number of total gastrectomy as a milestone in the
management of patients undergoing gastric cancer surgery to Dr. Ripollés-Melchor reports personal fees from Edwards
improve postoperative outcomes.32 We found similar results, Lifesciences, Vifor Pharma, MSD and Fresenius Kabi outside
Please cite this article in press as: Ripollés-Melchor J, et al. Association between use of enhanced recovery after surgery protocols and
postoperative complications after gastric surgery for cancer (POWER 4): a nationwide, prospective multicentre study. Cir Esp. 2023. http://
dx.doi.org/10.1016/j.cireng.2023.04.011
CIRENG 2881 1–13
the submitted work. Dr. Alfredo Abad-Gurumeta reports Rafael López-Pardo1,2 (Surgery Department); Marta Torres-
personal fees from Edwards Lifesciences, MSD, 3 M, Braun, Montalvo (Anesthesia Department)
Ferrer, Rovi and ALTAN outside the submitted work. Dr. Complejo Hospitalario Don Benito Villanueva de la Serena
Aldecoa reports personal fees from Fresenius Kabi and Isabel Pinilla-Pico, Enrique del-Cojo-Peces1,2, Marı́a del Pilar
Octapharma outside the submitted work. Dr Garcı́a-Erce Rodrı́guez-Chaparro (Anesthesia Department)
declares no conflict of interest with this study. However, he Complejo Hospitalario Universitario A Coruña
has previously given talks, chaired tables at congresses and Manuel Ángel Gómez-Rı́os1,2, Sara del-Rı́o-Regueira, Eva
conferences and organized courses with scholarships or Mosquera-Rodrı́guez (Anesthesia Department)
funding from Amgen, Jansen, Sandoz, Vifor Pharma and Complejo Hospitalario Universitario de Canarias
Zambon. Carlos Jericó has given talks and received consul- Jessica Hernández-Beslmeisl1,2, Marı́a Alejandra Perozo-
tancy fees from Viphor Pharma España SL, Bial and Zambon. Medina1, Beneharo Darias-Delbey, Marı́a del Carmen Martı́n-
Ane Abad-Motos, Marcos Bruna-Esteban, Marı́a Garcı́a- Lorenzo, Vanessa González-Fariña, Montserrat Rodrı́guez-
Nebreda, Isabel Otero-Martı́nez, Omar Abdel-lah Fernández, Domı́nguez, Jaime Fernández-de-la-Vega-Medina, Pilar Berro-
Marı́a P. Tormos-Pérez, Gloria Paseiro-Crespo, Raquel Garcı́a- tarán-Ayub (Anesthesia Department)
Álvarez, Marı́a A Mayo-Ossorio, Orreaga Zugasti-Echarte, Complejo Hospitalario Universitario Insular Materno
Paula Nespereira-Garcı́a, Lucia Gil-Gómez, Margarita Infantil de Gran Canaria
Logroño-Ejea, Raquel Risco, Felipe C Parreño-Manchado, Silvia José Valı́n-Martı́nez1,2, Laura Concepción-Santana, Raúl
Gil-Trujillo, Carmen Benito, Marı́a I De-Miguel-Cabrera, Cruz-Zorio, Dolores Betancort-Gutiérrez Rodrı́guez (Anesthe-
Bakarne Ugarte-Sierra, Cristina Barragán-Serrano, Henar sia Department)
Muñoz-Hernández, Sabela del- Rı́o-Fernández, Marı́a L. Complexo Hospitalario Universitario de Ourense
Herrero-Bogajo, Alma M. Espinosa-Moreno, Vanessa Concep- Leticia Gómez-Viana1,2, Olalla Figueiredo, Ariadna Rodrı́-
ción-Martı́n, Andrés Zorrilla-Vaca, Laura Vaquero-Pérez, Irene guez, Manuel González (Anesthesia Department); David
Mojarro, Manuel Llácer-Pérez, Leticia Gómez-Viana, Marı́a T. Iglesias, José Manuel Domı́nguez-Carrera (Surgery Depart-
Fernández-Martı́n, Carlos Ferrando-Ortolà, José M. Ramı́rez- ment); Jorge do Olmo (Adminisitrative support)
Rodrı́guez report no potential conflicts of interest. Complexo Hospitalario Universitario de Santiago
Sabela Del-Rı́o-Fernández1,2, Laura Dos-Santos-Carregal,
Marı́a Jesús Rodrı́guez-Forja, Olga Campaña-Figueira, Julián
POWER 4 Investigators Group Álvarez-Escudero (Anesthesia Department); Lucı́a Lesque-
reux-Martı́nez, Purificación Parada-González, Ricardo Monte-
Althaia. Xarxa Assistencial i Universitària de Manresa negro-Romero, Manuel Bustamante-Montalvo (Surgery
Mercè Güell Farré1,2, Roser Farré Font, Rafael Diaz del Department); Ana Rosa Garcı́a-Placı́n, Carmen Carpintero-
Gobbo, Raquel Sánchez Jimenez (Surgery Department) Isabel Rama, Sergio Brea-Bahamonde (Nursing Department)
Pérez Reche, Belen Gil Calvo, Jordi Llorca Garcı́a, Laura Fundación Jı́menez Dı́az
Carrasco Sánchez, Cristina Prat llimargas (Anesthesia Depart- José Ramón Torres-Alfonso1, Cristina Barragán-Serrano1,2,
ment). Marı́a Posada-González, Gabriel Salcedo-Cabañas, Peter Vor-
Complejo Asistencial de Zamora wald-Wolfgang (Surgery Department)
Ana Marı́a Garcı́a-Sánchez1, Gema Martı́nez-Ragüés1, Hospital Álvaro Cunqueiro de Vigo (Complejo Hospitalario
Marı́a Gómez-Fernández (Anesthesia Department); Álvaro Universitario de Vigo)
del-Castillo-Criado2, Ruth Martı́nez-Dı́az, Sara Alegrı́a-Rebollo Isabel Otero-Martı́nez1,2, Patricia Jove-Alborés, Marta López-
(Surgery Department) Otero, Hermelinda Pardellas-Rivera, Ignacio Maruri-Chimeno,
Complejo Asistencial Universitario de León Sonia González-Fernández, Raquel Sánchez-Santos (Surgery
Javier Ferrero-de-Paz1,2, Cristina Garcı́a-Pérez, Sergio Mar- Department); Luis Luna-Mendoza (Anesthesia Department)
cos-Contreras, Diana Fernández-Garcı́a, Maeva Torı́o-Marcos Hospital Arnau de Vilanova, Valencia
(Anesthesia Department) Enrique Lloria-Pons1,2, Francisco Gramuntell-Marco
Complejo Asistencial Universitario de Salamanca (Anesthesia Department) ; Raúl Cánovas-de-Lucas, Cristina
Omar Abdel-lah Fernández1,2, Felipe Carlos Parreño-Man- Sancho-Moya (Surgery Department)
chado1 (Surgery Department); Marı́a Ángeles Martı́n (Anest- Hospital Clı́nic de Barcelona
hesia Department) Raquel Risco1,2, Anna Fernández-Esmerats, Josep Martı́
Complejo Hospitalario de Mérida Sanahuja-Blasco, Manuel López-Baamonde, Marta Ubré, Gra-
José Marı́a Tena-Guerrero1,2, Estefanı́a Palma-González ciela Martı́nez-Pallı́ (Anesthesia Department); Dulce Momblán
(Anesthesia Department); Gustavo Flores-Flores1 (Surgery (Surgery Department); Nuria Rivas-Gallardo (Nurse)
Department) Hospital Clı́nico San Carlos
Complejo Hospitalario de Navarra Rubén Sánchez-Martı́n1,2, Pedro Moral, Rosalı́a Navarro,
Orreaga Zugasti-Echarte1,2, Elena Pérez-Bergara, Susana Luis Santé (Anesthesia Department); Esther Almenta (Surgery
Hernández-Garcı́a, Marta Martı́n-Vizcaı́no, Francisco Javier Department)
Yoldi-Murillo, Maider Valencia-Alzueta (Anesthesia Depart- Hospital Clı́nico Universitario de Valladolid
ment); Carlos Chaveli-Dı́az, Coro Miranda-Murua, Concepción Henar Muñoz-Hernández1,2, Rita Pilar Rodrı́guez-Jiménez,
Yárnoz-Irazábal (Surgery Department); Sonsoles Botella-Mar- Nuria Ruiz, Marı́a Teresa Peláez, Juan José Rojo, Carlota
tı́nez (Nutrition Department) Gordaliza (Anesthesia Department); Carlos Jezieniecki (Sur-
Complejo Hospitalario de Toledo gery Department)
Please cite this article in press as: Ripollés-Melchor J, et al. Association between use of enhanced recovery after surgery protocols and
postoperative complications after gastric surgery for cancer (POWER 4): a nationwide, prospective multicentre study. Cir Esp. 2023. http://
dx.doi.org/10.1016/j.cireng.2023.04.011
CIRENG 2881 1–13
Please cite this article in press as: Ripollés-Melchor J, et al. Association between use of enhanced recovery after surgery protocols and
postoperative complications after gastric surgery for cancer (POWER 4): a nationwide, prospective multicentre study. Cir Esp. 2023. http://
dx.doi.org/10.1016/j.cireng.2023.04.011
CIRENG 2881 1–13
Please cite this article in press as: Ripollés-Melchor J, et al. Association between use of enhanced recovery after surgery protocols and
postoperative complications after gastric surgery for cancer (POWER 4): a nationwide, prospective multicentre study. Cir Esp. 2023. http://
dx.doi.org/10.1016/j.cireng.2023.04.011
CIRENG 2881 1–13
(Surgery Department); Lorena Blanes-Pastor, Jose Luis Jover- (ERAS1) Society recommendations. Br J Surg. 2014;101:1209–
Pinillos (Anesthesia Department) 29.
9. Jeong O, Jang A, Jung MR, Kang JH, Ryu SY. The benefits of
MD Anderson Cancer Center Madrid
enhanced recovery after surgery for gastric cancer: A large
David Salvaterra1,2, Manuel Linero, Javier Galipienzo
before-and-after propensity score matching study. Clin
(Anesthesia Department); Nutr. 2021;40:2162–8.
Óscar Alonso, Gloria Ortega, Santiago Gonzalez, Irene 10. Polle SW, Wind J, Fuhring JW, Hofland J, Gouma DJ,
Lopez-Rojo (Surgery Department); Bemelman WA. Implementation of a fast-track
perioperative care program: what are the difficulties? Dig
Surg. 2007;24:441–9.
11. Zorrilla-Vaca A, Mena GE, Ripolles-Melchor J, Lorente JV,
Acknowledgments
Ramirez-Rodriguez JJM, Grant MC. Risk factors for acute
kidney injury in an enhanced recovery pathway for
Javier Garcı́a-Fernández as President Elect of the Spanish colorectal surgery. Surg Today. 2021;51:537–44.
Society of Anesthesiology and Critical Care (SEDAR); the 12. Abad-Motos A, Ripollés-Melchor J, Bruna-Esteban M,
Spanish Surgeons Association (AEC), and the European Society Ferrando-Ortolá C, Paseiro-Crespo G, Abad-Gurumeta A,
of Regional Anaesthesia and Pain Management-Spain (ESRA et al. Postoperative Outcomes Within an Enhanced Recovery
after surgery protocol in gastric surgery for cancer
Spain) provided non compensated pre recruitment announ-
(POWER.4): Study protocol for a prospective, multicentre,
cement of the study on their websites and social networks.
observational cohort study. Rev Esp Anestesiol Reanim (Engl
Alejandro Bona-Enguita (GERM Secretary) was the POWER 4 Ed). 2020;67:130–8.
website webmaster. Alberto Cebollada-Solanas provided 13. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC,
statistical analysis. No financial compensation was provided. Vandenbroucke JP. The Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) Statement:
guidelines for reporting observational studies. Int J Surg.
2014;12:1495–9.
Appendix A. Supplementary data
14. Elias KM, Stone AB, McGinigle K, Tankou JAI, Scott MJ,
Fawcett WJ, et al. The Reporting on ERAS Compliance,
Supplementary material related to this article can be Outcomes, and Elements Research (RECOvER) Checklist: A
found, in the online version, at doi:https://doi.org/10.1016/j. Joint Statement by the ERAS1 and ERAS1 USA Societies.
ciresp.2023.02.009. World J Surg. 2019;43.
15. Castor Electronic Data Capture. Ciwit BV. Amsterdam, the
Netherlands; 2018.
references 16. Jammer I, Wickboldt N, Sander M, Smith A, Schultz MJ,
Pelosi P, et al. Standards for definitions and use of outcome
measures for clinical effectiveness research in perioperative
medicine: European Perioperative Clinical Outcome (EPCO)
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram
definitions: A statement from the ESA-ESICM joint taskforce
I, Jemal A, et al. Global Cancer Statistics 2020:
on perioperative outcome measures. Eur J Anaesthesiol.
GLOBOCAN Estimates of Incidence and Mortality
2015;32:88–105.
Worldwide for 36 Cancers in 185 Countries. CA Cancer J
17. Wang L-H, Zhu R-F, Gao C, Wang S-L, Shen L-Z. Application
Clin. 2021;71:209–49.
of enhanced recovery after gastric cancer surgery: An
2. Papenfuss WA, Kukar M, Oxenberg J, Attwood K, Nurkin S,
updated meta-analysis. World J Gastroenterol. 2018;24:1562–
Malhotra U, et al. Morbidity and mortality associated with
78.
gastrectomy for gastric cancer. Ann Surg Oncol.
18. Blumenthaler AN, Robinson KA, Kruse BC, Munder K, Ikoma
2014;21:3008–14.
N, Mansfield PF, et al. Implementation of a perioperative-
3. Sah BK, Zhu ZG, Wang XY, Yang QM, Chen MM, Xiang M,
enhanced recovery protocol in patients undergoing open
et al. Post-operative complications of gastric cancer surgery:
gastrectomy for gastric cancer. J Surg Oncol. 2021. http://
female gender at high risk. Eur J Cancer Care (Engl).
dx.doi.org/10.1002/jso.26591. Online ahead of print.
2009;18:202–8.
19. Barbero M, Garcı́a J, Alonso I, Alonso L, San Antonio-San
4. Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after
Román B, Molnar V, et al. ERAS protocol compliance impact
surgery a review. JAMA Surg. 2017;1(152):292–8.
on functional recovery in colorectal surgery. Cir Esp.
5. Ljungqvist O, Young-Fadok T, Demartines N. The History of
2021;99:108–14.
Enhanced Recovery After Surgery and the ERAS Society. J
20. Pernazza G, Mancini R, Marino P. ERAS guidelines adherence
Laparoendosc Adv Surg Tech A. 2017;27:860–2.
and outcome correlation in colorectal surgery: 100 patients
6. Gustafsson UO, Hausel J, Thorell A, Ljungqvist O, Soop M,
experience. Clinical Nutrition ESPEN. 2019;31:143–4.
Nygren J. Adherence to the enhanced recovery after surgery
21. Tian Y-L, Cao S-G, Liu X-D, Li Z-Q, Liu G, Zhang X-Q, et al.
protocol and outcomes after colorectal cancer surgery. Arch
Short- and long-term outcomes associated with enhanced
Surg. 2011;146:571–7.
recovery after surgery protocol vs conventional
7. Ripollés-Melchor J, Ramı́rez-Rodrı́guez JM, Casans-Francés
management in patients undergoing laparoscopic
R, Aldecoa C, Abad-Motos A, Logroño-Egea M, et al.
gastrectomy. World J Gastroenterol. 2020;26:5646–60.
Association between Use of Enhanced Recovery after
22. Yamada T, Hayashi T, Cho H, Yoshikawa T, Taniguchi H,
Surgery Protocol and Postoperative Complications in
Fukushima R, et al. Usefulness of enhanced recovery after
Colorectal Surgery: The Postoperative Outcomes Within
surgery protocol as compared with conventional
Enhanced Recovery after Surgery Protocol (POWER) Study.
perioperative care in gastric surgery. Gastric cancer Off J Int
JAMA Surg. 2019;1–11.
Gastric Cancer Assoc Japanese Gastric Cancer Assoc.
8. Mortensen K, Nilsson M, Slim K, Schäfer M, Mariette C,
2012;15:34–41.
Braga M, et al. Consensus guidelines for enhanced recovery
23. Desiderio J, Stewart CL, Sun V, Melstrom L, Warner S, Lee B,
after gastrectomy: Enhanced Recovery After Surgery
et al. Enhanced Recovery after Surgery for Gastric Cancer
Please cite this article in press as: Ripollés-Melchor J, et al. Association between use of enhanced recovery after surgery protocols and
postoperative complications after gastric surgery for cancer (POWER 4): a nationwide, prospective multicentre study. Cir Esp. 2023. http://
dx.doi.org/10.1016/j.cireng.2023.04.011
CIRENG 2881 1–13
Patients Improves Clinical Outcomes at a US Cancer Center. 29. Smart NJ, White P, Allison AS, Ockrim JB, Kennedy RH,
J Gastric Cancer. 2018;18:230–41. Francis NK. Deviation and failure of enhanced recovery after
24. Ripollés-Melchor J, Abad-Motos A, Dı́ez-Remesal Y, surgery following laparoscopic colorectal surgery: early
Aseguinolaza-Pagola M, Padin-Barreiro L, Sánchez-Martı́n R, prediction model. Color Dis Off J Assoc Coloproctology Gt
et al. Association Between Use of Enhanced Recovery After Britain Irel. 2012;14:e727–34.
Surgery Protocol and Postoperative Complications in Total 30. Lu Y-X, Wang Y-J, Xie T-Y, Li S, Wu D, Li X-G, et al. Effects of
Hip and Knee Arthroplasty in the Postoperative Outcomes early oral feeding after radical total gastrectomy in gastric
Within Enhanced Recovery After Surgery Protocol in Elective cancer patients. World J Gastroenterol. 2020;26:5508–19.
Total Hip and Knee Arthroplasty Study (POWER2). JAMA 31. Slim K, Reymond T, Joris J, Paul S, Pereira B, Cotte E.
Surg. 2020;1:155. e196024. Intolerance to early oral feeding in enhanced recovery after
25. Ripollés-Melchor J, de Fuenmayor-Varela ML, Camargo SC, colorectal surgery: an early red flag? Color Dis Off J Assoc
Fernández PJ, Del Barrio ÁC, Martı́nez-Hurtado E, et al. Coloproctology Gt Britain Irel. 2020;22:95–101.
[Enhanced recovery after surgery protocol versus 32. Griffin SM, Kamarajah SK, Navidi M, Wahed S, Immanuel A,
conventional perioperative care in colorectal surgery. A Hayes N, et al. Evolution of gastrectomy for cancer over 30-
single center cohort study]. Brazilian J Anesthesiol. years: Changes in presentation, management, and
2018;68:358–68. outcomes. Surgery. 2021;170:2–10.
26. Dean HF, Carter F, Francis NK. Modern perioperative 33. Ripolles-Melchor J, Casans-Frances R, Espinosa A, Abad-
medicine - past, present, and future. Innov Surg Sci. Gurumeta A, Feldheiser A, Lopez-Timoneda F, et al. Goal
2019;5(4):123–31. directed hemodynamic therapy based in esophageal
27. Memtsoudis SG, Poeran J, Kehlet H. Enhanced Recovery after Doppler flow parameters: A systematic review, meta-
Surgery in the United States: From Evidence-Based Practice analysis and trial sequential analysis. Rev Esp Anestesiol
to Uncertain Science? JAMA - J Am Med Assoc. Reanim. 2016;63:384–405.
2019;321:1049–50. 34. Ripolles-Melchor J, Espinosa A, Martinez-Hurtado E, Abad-
28. Gemma M, Pennoni F, Braga M. Studying Enhanced Recovery Gurumeta A, Casans-Frances R, Fernandez-Perez C, et al.
After Surgery (ERAS1) Core Items in Colorectal Surgery: A Perioperative goal-directed hemodynamic therapy in
Causal Model with Latent Variables. World J Surg. noncardiac surgery: a systematic review and meta-analysis.
2021;45:928–39. J Clin Anesth. 2016;28:105–15.
Please cite this article in press as: Ripollés-Melchor J, et al. Association between use of enhanced recovery after surgery protocols and
postoperative complications after gastric surgery for cancer (POWER 4): a nationwide, prospective multicentre study. Cir Esp. 2023. http://
dx.doi.org/10.1016/j.cireng.2023.04.011